Prediction of the active compounds and mechanism of Biochanin A in the treatment of Legg-Calvé-Perthes disease based on network pharmacology and molecular docking

MLA

Jianhong Liu, et al. “Prediction of the Active Compounds and Mechanism of Biochanin A in the Treatment of Legg-Calvé-Perthes Disease Based on Network Pharmacology and Molecular Docking.” BMC Complementary Medicine and Therapies, vol. 24, no. 1, Jan. 2024, pp. 1–15. EBSCOhost, https://doi.org/10.1186/s12906-023-04298-w.

APA

Jianhong Liu, Zhirui Hua, Shijie Liao, Boxiang Li, Shengping Tang, Qian Huang, Zhendi Wei, Rongbin Lu, Chengsen Lin, & Xiaofei Ding. (2024). Prediction of the active compounds and mechanism of Biochanin A in the treatment of Legg-Calvé-Perthes disease based on network pharmacology and molecular docking. BMC Complementary Medicine and Therapies, 24(1), 1–15. https://doi.org/10.1186/s12906-023-04298-w

Chicago

Jianhong Liu, Zhirui Hua, Shijie Liao, Boxiang Li, Shengping Tang, Qian Huang, Zhendi Wei, Rongbin Lu, Chengsen Lin, and Xiaofei Ding. 2024. “Prediction of the Active Compounds and Mechanism of Biochanin A in the Treatment of Legg-Calvé-Perthes Disease Based on Network Pharmacology and Molecular Docking.” BMC Complementary Medicine and Therapies 24 (1): 1–15. doi:10.1186/s12906-023-04298-w.